FDA, NIH Among Speakers at Pediatric Clinical Studies Conference

Pediatric Study Plans, Ethical Considerations among Sessions on Meeting Agenda.

Chicago, IL, January 15, 2016 --(PR.com)-- Speakers from the FDA will join leaders in the industry at the Pediatric Clinical Studies for Pharmaceutical and Device Products Conference April 11-12, 2016 in Arlington, VA. This conference, hosted by Q1 Productions, will address the most top-of-mind concerns in the pediatric clinical studies industry.

The two-day event will include presentations on pediatric clinical research guidance, both in the United States and abroad. In addition, representatives from organizations like Kids v. Cancer and iCAN will speak about how the field continues to evolve and advance. Attendees will also have the chance to engage with a hypothetical informed consent document with legal professionals.

Join distinguished speakers such as Robert Nelson of the FDA and Cheryl Pikora of Takeda in discussions that will tackle the unique challenges facing this field.

For more information on the Pediatric Clinical Studies for Pharmaceutical and Device Products Conference, visit www.q1productions.com/pediatric-clinical-studies or email marketing@q1productions.com. You can also follow the conference on Twitter @Q1Productions, #Q1PedCR.

About the Organizer
Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences throughout highly regulated industries in order to provide strategic learning and timely program content. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues or enhanced technologies or processes that will drive efficiency, our programs provide solutions to the urgent educational and information needs of our attendees.
Q1 Productions
Paul Hernandez
Fax: (312) 873-3969